These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 20458083)

  • 41. Loop diuretic use and fracture in postmenopausal women: findings from the Women's Health Initiative.
    Carbone LD; Johnson KC; Bush AJ; Robbins J; Larson JC; Thomas A; LaCroix AZ
    Arch Intern Med; 2009 Jan; 169(2):132-40. PubMed ID: 19171809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fracture risk and bone mineral density reduction associated with proton pump inhibitors.
    Lau YT; Ahmed NN
    Pharmacotherapy; 2012 Jan; 32(1):67-79. PubMed ID: 22392829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in site-specific fracture risk among older women with discordant results for osteoporosis at hip and spine: study of osteoporotic fractures.
    Fink HA; Harrison SL; Taylor BC; Cummings SR; Schousboe JT; Kuskowski MA; Stone KL; Ensrud KE;
    J Clin Densitom; 2008; 11(2):250-9. PubMed ID: 18296090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between hand-grip strength and site-specific risks of major osteoporotic fracture: Results from the Japanese Population-based Osteoporosis Cohort Study.
    Kamiya K; Kajita E; Tachiki T; Ikehara S; Kouda K; Sato Y; Tamaki J; Kagamimori S; Iki M
    Maturitas; 2019 Dec; 130():13-20. PubMed ID: 31706431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
    Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
    Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between post-stroke disability and 5-year hip-fracture risk: The Women's Health Initiative.
    Northuis CA; Crandall CJ; Margolis KL; Diem SJ; Ensrud KE; Lakshminarayan K
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104976. PubMed ID: 32689623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment.
    Miller PD; Siris ES; Barrett-Connor E; Faulkner KG; Wehren LE; Abbott TA; Chen YT; Berger ML; Santora AC; Sherwood LM
    J Bone Miner Res; 2002 Dec; 17(12):2222-30. PubMed ID: 12469916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.
    Siris ES; Miller PD; Barrett-Connor E; Faulkner KG; Wehren LE; Abbott TA; Berger ML; Santora AC; Sherwood LM
    JAMA; 2001 Dec; 286(22):2815-22. PubMed ID: 11735756
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Magnesium intake, bone mineral density, and fractures: results from the Women's Health Initiative Observational Study.
    Orchard TS; Larson JC; Alghothani N; Bout-Tabaku S; Cauley JA; Chen Z; LaCroix AZ; Wactawski-Wende J; Jackson RD
    Am J Clin Nutr; 2014 Apr; 99(4):926-33. PubMed ID: 24500155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incident fracture is associated with a period of accelerated loss of hip BMD: the Study of Osteoporotic Fractures.
    Christiansen BA; Harrison SL; Fink HA; Lane NE;
    Osteoporos Int; 2018 Oct; 29(10):2201-2209. PubMed ID: 29992510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychotropic medications and proton pump inhibitors and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.
    Kendler DL; Marin F; Geusens P; López-Romero P; Lespessailles E; Body JJ; Minisola S
    Bone; 2020 Jan; 130():115113. PubMed ID: 31654779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone mineral density changes among women initiating proton pump inhibitors or H2 receptor antagonists: a SWAN cohort study.
    Solomon DH; Diem SJ; Ruppert K; Lian YJ; Liu CC; Wohlfart A; Greendale GA; Finkelstein JS
    J Bone Miner Res; 2015 Feb; 30(2):232-9. PubMed ID: 25156141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.
    Trémollieres FA; Pouillès JM; Drewniak N; Laparra J; Ribot CA; Dargent-Molina P
    J Bone Miner Res; 2010 May; 25(5):1002-9. PubMed ID: 20200927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization.
    Karim R; Dell RM; Greene DF; Mack WJ; Gallagher JC; Hodis HN
    Menopause; 2011 Nov; 18(11):1172-7. PubMed ID: 21775911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Digital X-ray radiogrammetry predicts hip, wrist and vertebral fracture risk in elderly women: a prospective analysis from the study of osteoporotic fractures.
    Bouxsein ML; Palermo L; Yeung C; Black DM
    Osteoporos Int; 2002 May; 13(5):358-65. PubMed ID: 12086345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial.
    Jackson RD; Wactawski-Wende J; LaCroix AZ; Pettinger M; Yood RA; Watts NB; Robbins JA; Lewis CE; Beresford SA; Ko MG; Naughton MJ; Satterfield S; Bassford T;
    J Bone Miner Res; 2006 Jun; 21(6):817-28. PubMed ID: 16753012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.
    Bilezikian JP; Lin CJF; Brown JP; Wang AT; Yin X; Ebeling PR; Fahrleitner-Pammer A; Franek E; Gilchrist N; Miller PD; Simon JA; Valter I; Zerbini CAF; Libanati C; Chines A
    Osteoporos Int; 2019 Sep; 30(9):1855-1864. PubMed ID: 31201481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proton pump inhibitor use is associated with hip fracture development: a nationwide population-based cohort study.
    Min YW; Lee YC; Kim K; Ryu S; Hong KS; Jeon HH; Kim YS; Park JH; Son HJ; Rhee PL
    Korean J Intern Med; 2020 Sep; 35(5):1084-1093. PubMed ID: 31671930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiepileptic drug use increases rates of bone loss in older women: a prospective study.
    Ensrud KE; Walczak TS; Blackwell T; Ensrud ER; Bowman PJ; Stone KL
    Neurology; 2004 Jun; 62(11):2051-7. PubMed ID: 15184613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies.
    Yu EW; Bauer SR; Bain PA; Bauer DC
    Am J Med; 2011 Jun; 124(6):519-26. PubMed ID: 21605729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.